Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes

AIDS Research and Human Retroviruses

Volumn 19, Issue 6, 2003, Pages 503-510

  Hossain, M Sohrab ^a,b   Tomiyama, Hiroko ^a   Inagawa, Takafumi ^a   Ida, Setsuko ^c   Oka, Shinichi ^c   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA A ANTIGEN; POL PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; HLA SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENETICS; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN MOTIF;

AMINO ACID SEQUENCE; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; GENE PRODUCTS, POL; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0038729195     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203766774559     Document Type: Article

References (24)

1. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I syndrome. J Virol 1994;68:4650-4655.
2. + T cells with a predominant V-usage during the primary immune response to HIV. Nature 1994;370:463-467.
3. Moss PA, Rowland-Jones S, Frodsham PM, et al.: Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA 1995;92:5773-5777.
4. Rowland-Jones S, Sutton J, Ariyoshi K et al.: HIV-1 specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
5. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, and Oksenhendler E: Human immunodeficiency virus (HIV) Nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994;93:1293-1297.
6. Klein MR, van Baalen CA, Holwerda AM, et al.: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
7. Borrow P, Lewicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-211.
8. Goulder PJ, Phillips RE, Colbert RA, et al.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-217.
9. Collins KL, Chen BK, Kalams SA, Walker BD, and Baltimore D: HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
10. Xu XN, Laffert B, Screaton GR, et al.: Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor ζ chain. J Exp Med 1999;189:1489-1496.
11. + T cells is mediated by macrophages through interaction of HIV gp 120 with chemokine receptor CXCR4. Nature 1998;395:189-194.
12. + T cells. Immunity. 2001;15:871-882.
13. Clayton J, Lonjon C, and Whittle D: Allele and haplotype frequencies for HLA loci in various ethnic groups. In: HLA, Vol. I: Genetic Diversity of HLA Functional and Medical Implications (Charron F, ed.). EDK Medical and Scientific International Publisher, Paris, 1997, pp. 665-820.
14. Shiga H, Shioda T, Tomiyama H, et al.: Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 1996;10:1075-1083.
15. Ikeda-Moore Y, Tomiyama H, Miwa K, et al.: Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: Strong epitopes are derived from V regions of HIV-1. J Immuol 1997;159:6242-6252.
16. Tomiyama H, Sakaguchi T, Miwa K, et al.: Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. Hum Immunol 1999;60:177-186.
17. Hossain MS, Tomiyama H, Inagawa T, Sriwanthana B, Oka S, and Takiguchi M: HLA-A*3303-restricted cytotoxic T lymphocyte recognition for novel epitopes derived from the highly variable region of the HIV-1 Env protein. AIDS 2001;15:2199-2208.
18. Karaki S, Kariyone A, Kato N, Kano K, Iwakura Y, and Takiguchi M: HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies. Immunogenetics 1993;37:139-142.
19. Takiguchi M, Matsuda T, Tomiyama H, and Miwa K: Analysis of three HLA-A*3303 binding peptide anchors using an HLA-A*3303 stabilization assay. Tissue Antigens 2000;55:296-302.
20. Tanabe M, Sekimata M, Ferrone S, and Takiguchi M: Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 1992;148:3202-3209.
21. Shioda T and Shibuta H: Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology 1990;175:139-148.
22. Falk K, Rotzschke O, Takiguchi M, et al.: Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 1994;40:238-241.
23. Takiguchi M, Matsuda T, and Tomiyama H: Polarity of the P1 anchor residue determines peptide binding specificity between HLA-A*3101 and HLA-A*3303. Tissue Antigens 2000;56:501-506.
24. Fukada K, Tomiyama H, Wasi C, et al.: Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients. AIDS 2002;16:701-711.